FdaApplication

ANDA 203934

Back to search

Identifiers

Properties

PropertyValue
applicant_nameZYDUS PHARMACEUTICALS USA INC
application_typeANDA
approval_date2024-01-24

Products (5)

ProductActive ingredientStrengthDosage form
GABAPENTINGABAPENTIN300MGTABLET;ORAL
GABAPENTINGABAPENTIN600MGTABLET;ORAL
GABAPENTINGABAPENTIN750MGTABLET;ORAL
GABAPENTINGABAPENTIN900MGTABLET;ORAL
GABAPENTINGABAPENTIN450MGTABLET;ORAL

5 products